A rare complication of acute or chronic pancreatitis is the formation of a mediastinal pancreatic pseudocyst (MPP), which is caused by tracking of pancreatic fluids through anatomical openings of the diaphragm into the mediastinum. Herein, we report the imaging characteristics of three cases of this condition. Our results revealed three features in common: (i) the connection between the mediastinum and the pancreatic cystic lesion; (ii) the presence of pleural effusions; and (iii) imaging findings consistent with chronic pancreatitis, such as pancreatic atrophy and calcifications and dilatation and/or stricture of main pancreatic duct (MPD). Serial diameter changes of the MPD and of the adjacent pseudocysts were necessary for the determination of the therapeutic strategy used in each case.
Introduction
Pancreatic pseudocysts are often caused by acute or chronic pancreatitis. Mediastinal pancreatic pseudocysts (MPPs) are rare complications of pancreatitis (1, 2) . An inflammatory disruption of the pancreatic duct leads to leakage of pancreatic secretions. Anterior ductal disruption often results in pancreatic ascites, whereas posterior ductal disruption results in thoracopancreatic fistula, which can be classified into MPP, pancreatico-pleural fistula, pancreaticobronchial fistula, or pancreatico-pericardial fistula (3) . Therefore, MPPs result from retroperitoneal extension of pancreatic fluids through the anatomical openings of the diaphragm into the mediastinum (1, 4) . MPPs may present with a triad of chest pain, dysphagia, and dyspnea (4) , although their diagnosis is sometimes difficult to make, especially in cases without abdominal pain.
A definitive diagnosis can be made by imaging modalities, such as computed tomography (CT) or magnetic resonance imaging (MRI), showing cystic lesions extending from the pancreas into the mediastinum (3, (5) (6) (7) (8) (9) . Management of MPPs depends upon their size, quantity, location, and relationship to adjacent anatomical structures, as well as the presence of communication of the cyst with the pancreatic duct (10, 11) . Furthermore, draining pancreatic fluid, which reduces pressure within the pseudocysts and pancreatic duct, is also important in managing patients with MPPs (4,10). We present three cases of MPPs and describe their clinical settings and imaging features.
Case reports

Case 1
A 58-year-old man presented with 3 weeks of dysphagia, which was experienced predominantly with solid foods. He had lost 3 kg in the last month. He had no past medical history. He had been a heavy drinker (1 L of beer per day) and a heavy smoker (20 cigarettes per day for 35 years). Laboratory tests showed the following: 162 U/L serum amylase (normal value <37-125 U/L), 160 IU/L serum lipase (normal value <6-53U/L), 172 mg/dl blood glucose, 8040/mL white blood cells, and 10.61 mg/dl C-reactive protein (CRP). Tumor markers (SCC, CEA, and CA19-9) were negative.
Upper gastrointestinal endoscopy showed mild narrowing of the lower esophagus. On chest and abdominal CT, cystic lesions extended from the abdomen into the mediastinum along with the esophagus and aorta, presumably via the esophageal and aortic hiatus. One of the mediastinal cysts also extended into the retrocrural space. Bilateral pleural effusions were seen. One of the abdominal cysts was connected to the pancreatic body. The main pancreatic duct (MPD) in the pancreatic tail was slightly dilated. A calcification was seen in the body of the pancreas (Fig. 1A-C) . A laparoscopic lymph node biopsy was performed due to the possibility of necrotic lymph node metastases. There were no malignant cells in the specimens. Conservative antibiotic therapy was administered. Two months' symptom after onset, repeat chest and abdominal CT images showed that the size of each cystic lesion had diminished. The patient was then diagnosed with pancreatic pseudocysts caused by chronic pancreatitis. Eight months after symptom onset, he returned with complaints of upper left abdominal pain. An abdominal CT indicated that the size of the cyst connected with the pancreatic body had increased (Fig. 1D) . CT-guided percutaneous drainage of the pancreatic cyst was performed and the size of the cyst was reduced. There was no increase in the size of the cyst upon further follow-up CT. He currently receives regular outpatient treatment. 
Case 2
A 65-year-old man presented with 3 months of abdominal fullness along with 3 days of continuous fever of approximately 38 C. He had no past medical history. He had been a heavy drinker (1.5 L of beer per day). Laboratory tests showed the following: 1259 U/L serum amylase, 819 IU/L serum lipase, 2.5 g/dl serum albumin, 9180/mL white blood cells, and 24.9 mg/dl CRP. Tumor markers (CEA and CA19-9) were negative. Upper gastrointestinal endoscopy did not show any remarkable findings. Chest and abdominal CT showed fluid collections with cystic lesions extending from the abdomen into the mediastinum along the esophagus via the esophageal hiatus. The connection between the mediastinal and abdominal lesions was well identified on a sagittal image ( Fig. 2A) . Bilateral pleural effusions were seen. Abdominal CT and MRI showed a small cyst and a slightly dilated MPD in the pancreatic body in addition to the peripancreatic cystic lesions (Fig. 2B) . The diagnosis of pancreatic pseudocyst was made. Under conservative antibiotic therapy, the mediastinal fluid collection and cystic lesions disappeared, although the peripancreatic cystic lesions were still present. Therefore, CT-guided percutaneous drainage of the dorsal cyst of the pancreatic body was performed along with the placement of a pigtail drainage catheter. Furthermore, an MPD stricture was seen in the pancreatic body on endoscopic retrograde cholangiopancreatography (ERCP). Consequently, a tube stent (7 Fr) was endoscopically placed in the MPD (Fig. 2C) . Three months later, amylase and lipase levels had normalized and the tube stent was removed. Eight months later, an abdominal CT indicated that both the cyst and the adjacent MPD were again slightly enlarged (Fig. 2D) . Finally, elective pancreaticojejunostomy of the body and tail of the pancreas was performed in another hospital.
Case 3
A 67-year-old man presented with 1 month of abdominal fullness and appetite loss and with several days of cough, sputum, and dyspnea. The patient had acute pancreatitis 3 years ago. He was also operated on for left lung cancer (stage IIIA) 2 years ago. He had been a heavy drinker (1 L of beer per day) and a heavy smoker (30 cigarettes per day for 45 years). Laboratory tests showed the following: 816 U/L serum amylase, 338 IU/L serum lipase, 11.8 g/dl hemoglobin, 8000/mL white blood cells, and 15.39 mg/dl CRP. Tumor markers (CEA and CA19-9) were negative. On chest and abdominal CT, fluid collections with cystic lesions extending from the abdomen into the mediastinum along the esophagus and inferior vena cava, presumably via the esophageal hiatus and inferior vena cava hiatus, were noted. Bilateral pleural effusions, pericardial effusions, and ascites were also seen. The connection between the mediastinal and abdominal cysts was clearly identified via sagittal images. An enlarged pancreatic head with multiple cysts and calcifications and a dilated MPD of the pancreas body and tail were seen (Fig. 3A-C) . Cytological examination of the pleural effusion and ascites was negative for malignant cells. The pleural effusion had a high amylase level (540 U/L). On ERCP, dilatation and irregularity of the side branches and an MPD stricture were seen in the pancreatic head region (Fig. 3D) . It was not possible to deeply cannulate the MPD in the pancreatic head region because of the focal narrowing of the MPD.
Endoscopic pancreatic ductal drainage was considered challenging. Elective pancreaticojejunostomy was performed in another hospital.
Discussion
Pancreatic pseudocysts are a major complication resulting from chronic or acute pancreatitis. Eighty percent of pancreatic pseudocysts are located within the head and body of the pancreas, and 20% are extrapancreatic and located in areas such as the pleura, mediastinum, liver, spleen, and pelvis (12) . MPPs belong to the category of thoracopancreatic fistula and occur as a result of posterior rupture of the pancreatic duct into the retroperitoneal space. Pancreatic fluids extend upward through anatomical openings of the diaphragm into the mediastinum. The fluids typically travel through the esophageal and aortic hiatus into the posterior mediastinum (1, 4) . If the diaphragm is penetrated through the inferior vena cava hiatus or the foramen of Morgagni, the fluid extends into the middle and anterior mediastinum, respectively (13) . Related symptoms may include chest pain, dysphagia, dyspnea secondary to an accompanying pleural effusion, and weight loss secondary to dysphagia. A history of pancreatitis or alcoholism may help in the diagnostic workup, although the above symptoms are rarely helpful as most mediastinal masses will present with similar symptoms due to compression of adjacent structures (10) . In our three cases, the following symptoms were seen: dysphagia and weight loss in case 1, abdominal fullness and fever in case 2, and abdominal fullness, appetite loss, cough, sputum production, and dyspnea in case 3. Therefore, it was difficult to suspect pancreatitis in all of our cases according to their symptoms at their initial presentations, although all of them were middle-aged men and heavy drinkers.
The definitive diagnosis is based on imaging studies showing cystic lesions extending from the pancreas into the mediastinum. CT is most commonly used to establish the diagnosis, and it also helps to depict pancreatitis and the connection between the mediastinal cystic structures and the pancreas (3) (4) (5) (6) (7) (8) . MRI and magnetic resonance cholangiopancreatography (MRCP) provide further details of pancreatic ductal anatomy (3, 6, 9, 10) . Recent advances in endoscopic techniques, such as endoscopic ultrasound (EUS), are helpful in evaluating the mediastinal mass and cysts and also play an important therapeutic role by allowing EUS-guided aspiration and drainage of the cysts (14) . In all of our cases, chest and abdominal CT showed mediastinal cystic lesions connected with pancreatic or peripancreatic cystic lesions via anatomical openings in the diaphragm. The abdominal cystic lesions connected with the posterior mediastinum via the esophageal hiatus in all cases, connected with the posterior mediastinum via the aortic hiatus and retrocrural space in case 1 and connected with the middle mediastinum via the inferior vena cava hiatus in case 3. Bilateral pleural effusions were also seen in all cases. Pancreatic atrophy or focal swelling, pancreatic calcifications, dilatation, and/or stricture of the MPD and pancreatic pseudocysts, whose findings are key findings of chronic pancreatitis, were seen in all cases on abdominal CT. The connection between mediastinal and abdominal lesions and various extension routes of pancreatic fluids through the diaphragm into the mediastinum were well identified on axial thin slice images and on coronal and/or sagittal reconstructed images. Furthermore, MRI and MRCP provided further details of pancreatic ductal dilatation and/or stricture.
Management of MPPs depends on their size, quantity, location, relationship with adjacent anatomical structures, the presence of infection or hemorrhage, the presence of communication of the cyst with the pancreatic duct, and symptom severity (10, 11) . Spontaneous regression is rare but has been reported to occur with complete abstinence from alcohol and with the use of total parenteral nutrition (15) . Successful resolution of the pseudocysts after medical therapy, such as octreotide and bromhexine hydrochloride, has also been reported (16, 17) . Draining pancreatic fluid and transpapillary stenting of the pancreatic duct are useful treatments that reduce the high pressures associated with pseudocysts and pancreatic duct narrowing (4, 10) . CT-guided percutaneous drainage or EUS-guided drainage is widely performed for draining pancreatic fluid. ERCP with transpapillary stenting of the pancreatic duct can be used when the pseudocyst communicates with the pancreatic duct (4, 10, (18) (19) (20) . Surgical treatment should be performed for patients with failure of the abovementioned less-invasive therapies, as well as patients with bleeding, infection, pseudocyst rupture, and acute lifethreatening presentations. Surgical options include internal drainage, external drainage, cyst-enterostomy, or pancreatic resection (21, 22) . In our three cases, CT and MRI were useful imaging modalities for evaluating the MPD diameter, the site of stenosis, the length of stricture, and the size and location of the pseudocysts. The use of these modalities allowed accurate evaluations of the sites of the pancreatic ductal stricture and of the serial changes in these lesions, which were necessary for the determination of the therapeutic strategy used in each case.
In conclusion, we present three cases of MPP and describe their clinical settings and radiological imaging features. A definitive diagnosis could be made via imaging modalities, such as CT or MRI, showing cystic lesions extending from the pancreas into the mediastinum. Precise assessments of pancreatic ductal stricture and pseudocysts and sufficient decompression of these lesions are essential in managing patients with MPP.
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